Mind Medicine (MindMed) Inc.
For the period ended Sep 30, 2025. Filed Nov 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 6, 2025
DFTX$35.39+6.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
| (in thousands, except share amounts) | September 30, 2025(unaudited) | December 31, 2024 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $19,959 | $273,741 |
| Short-term investments | 189,111 | — |
| Prepaid and other current assets | 6,778 | 7,879 |
| Total current assets | 215,848 | 281,620 |
| Goodwill | 19,918 | 19,918 |
| Other non-current assets | 1,150 | 613 |
| Total assets | $236,916 | $302,151 |
| Liabilities and Shareholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $8,113 | $2,010 |
| Accrued expenses | 19,028 | 12,829 |
| 2022 USD Financing Warrants | 38,275 | 24,010 |
| Total current liabilities | 65,416 | 38,849 |
| Credit facility, long-term | 40,385 | 21,854 |
| Other non-current liabilities | 519 | — |
| Total liabilities | 106,320 | 60,703 |
| Commitments and contingencies (Note 10) | ||
| Shareholders' equity: | ||
| Common shares, no par value, unlimited authorized as of September 30, 2025 and December 31, 2024; 76,774,057 and 75,100,763 issued and outstanding as of September 30, 2025 and December 31, 2024, respectively | — | — |
| Additional paid-in capital | 661,831 | 639,508 |
| Accumulated other comprehensive income | 1,001 | 819 |
| Accumulated deficit | (532,236) | (398,879) |
| Total shareholders' equity | 130,596 | 241,448 |
| Total liabilities and shareholders' equity | $236,916 | $302,151 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.